Dr. Shah is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
335 Glessner Ave
Mansfield, OH 44903Phone+1 567-241-7237- Is this information wrong?
Summary
- Dr. Hiral Shah is an oncologist in Mansfield, OH and is affiliated with multiple hospitals in the area, including Ohio State University Wexner Medical Center and James Cancer Hospital and Solove Research Institute. She received her medical degree from Northeast Ohio Medical University and has been in practice 7 years. She specializes in hematologic oncology and melanoma and is experienced in hematologic oncology.
Education & Training
Northwestern Memorial HospitalDevelopmental Therapeutics Program, 2016 - 2017
University of Illinois College of Medicine at ChicagoFellowship, Hematology and Medical Oncology, 2013 - 2016
Loyola University Medical CenterResidency, Internal Medicine, 2010 - 2013
Northeast Ohio Medical UniversityClass of 2010
Certifications & Licensure
OH State Medical License 2017 - 2026
CO State Medical License 2022 - 2025
IL State Medical License 2010 - 2020- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 11 citationsEffect of Immune Checkpoint Blockade on Myeloid-Derived Suppressor Cell Populations in Patients With Melanoma.Steven Sun, Brooke Benner, Himanshu Savardekar, Gabriella Lapurga, Logan Good, David Abood, Erin Nagle, Megan C. Duggan, Andrew Stiff, Mallory J. DiVincenzo, Lorena P....> ;Frontiers in Immunology. 2021 Oct 12
- 13 citationsAssociation of Population Screening for Breast Cancer Risk With Use of Mammography Among Women in Medically Underserved Racial and Ethnic Minority Groups.Candice Schwartz, Ifeanyi Beverly Chukwudozie, Silvia Tejeda, Ganga Vijayasiri, Ivy Abraham, Mylene Hernandez Remo, Hiral A. Shah, Maria Rojas, Alicia Carillo, Loraine...> ;JAMA Network Open. 2021 Sep 1
- 12 citationsPhase I Study of Aurora A Kinase Inhibitor Alisertib (MLN8237) in Combination With Selective VEGFR Inhibitor Pazopanib for Therapy of Advanced Solid Tumors.Hiral A. Shah, James H. Fischer, Neeta K. Venepalli, Oana Cristina Danciu, Sonia Christian, Meredith J Russell, Li C Liu, James P. Zacny, Arkadiusz Z. Dudek> ;American Journal of Clinical Oncology. 2019 May 1
- Join now to see all
Hospital Affiliations
Ohio State University Wexner Medical CenterColumbus, Ohio
The OSUCCC - JamesColumbus, Ohio
OhioHealth Mansfield HospitalMansfield, Ohio
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
